USPTO serial 79337464
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
CZ
CZ-170 00 PRAGUE 7, CZ
CZ-170 00 PRAGUE 7, CZ
CZ-170 00 PRAGUE 7, CZ
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Shane Rumbaugh
Shane Rumbaugh Rumbaugh Law PLLC2400 Ansys Drive, Suite 102Canonsburg, PA 15317United States| Class | Description | Status | First use |
|---|---|---|---|
| 039 | Labeling, relabeling, storage and distribution of cell therapy materials | ACTIVE | — |
| 040 | Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, CAR-T therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, TCR-T therapy materials, namely, T cell receptor T cell-based pharmaceuticals, and CAR-NK therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals, to the order and specification of others | ACTIVE | — |
| 042 | Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; product research and development, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies; contract research services in the field of cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, and CAR-NK therapies | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 5, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 5, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 5, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 4, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 13, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 13, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 9, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 22, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 3, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 3, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 20, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 20, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 20, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 20, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 20, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 5, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 4, 2024 | ALIE | ASSIGNED TO LIE | — |
| Feb 16, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 16, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 16, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 13, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2023 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Oct 13, 2023 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Oct 13, 2023 | PETG | PETITION TO REVIVE-GRANTED | — |
| Oct 13, 2023 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Oct 3, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 13, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 13, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 14, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 14, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 14, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 14, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 25, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 25, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 20, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 25, 2022 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Nov 24, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 23, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 22, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 18, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 12, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 8, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 7, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |